Heart rate as a risk factor for developing chronic kidney disease: Longitudinal analysis of a screened cohort

Clinical and Experimental Nephrology

Volumn 13, Issue 5, 2009, Pages 487-493

  Inoue, Taku ^a   Iseki, Kunitoshi ^b   Iseki, Chiho ^b   Ohya, Yusuke ^a   Kinjo, Kozen ^c   Takishita, Shuichi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^c Okinawa General Health Maintenance Association   (Japan)

Author keywords

Chronic kidney disease; Epidemiology; Heart rate; Prevention

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEINURIA;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HEART RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; YOUNG ADULT;

EID: 70349684484     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0193-3     Document Type: Article

References (35)

1. WB Kannel C Kannel RS Paffenbarger Jr LA Cupples 1987 Heart rate and cardiovascular mortality: the Framingham Study Am Heart J 113 1489 1494 3591616 10.1016/0002-8703(87)90666-1 1:STN:280:DyaL2s3jvVentA%3D%3D (Pubitemid 17092823)
2. RF Gillum DM Makuc JJ Feldman 1991 Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study Am Heart J 121 172 177 1985358 10.1016/0002-8703(91)90970-S 1:STN:280:DyaK3M%2FovF2mtQ%3D%3D
3. P Palatini E Casiglia S Julius AC Pessina 1999 High heart rate: a risk factor for cardiovascular death in elderly men Arch Intern Med 159 585 592 10090115 10.1001/archinte.159.6.585 1:STN:280:DyaK1M7ovVGjsw%3D%3D (Pubitemid 29133883)
4. Y Fujiura H Adachi M Tsuruta DR Jacobs Jr Y Hirai T Imaizumi 2001 Heart rate and mortality in a Japanese general population: an 18-year follow-up study J Clin Epidemiol 54 495 500 11337213 10.1016/S0895-4356(00)00323-1 1:STN:280:DC%2BD3M3ovVCjsg%3D%3D (Pubitemid 32416453)
5. J Coresh BC Astor T Greene G Eknoyan AS Levey 2003 Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 1 12 12500213 10.1053/ajkd.2003.50007
6. J Coresh D Byrd-Holt BC Astor JP Briggs PW Eggers DA Lacher, et al. 2005 Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000 J Am Soc Nephrol 16 180 188 15563563 10.1681/ASN.2004070539 (Pubitemid 43073171)
7. K Iseki C Iseki Y Ikemiya K Fukiyama 1996 Risk of developing end-stage renal disease in a cohort of mass screening Kidney Int 49 800 805 8648923 10.1038/ki.1996.111 1:STN:280:DyaK283jtFaltA%3D%3D (Pubitemid 26093091)
8. MJ Sarnak AS Levey AC Schoolwerth J Coresh B Culleton LL Hamm, et al. 2003 Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2154 2169 14581387 10.1161/01.CIR.0000095676.90936.80 (Pubitemid 37337595)
9. AS Go GM Chertow D Fan CE McCulloch CY Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296 1305 15385656 10.1056/NEJMoa041031 1:CAS:528:DC%2BD2cXnvFSgtr8%3D (Pubitemid 39268908)
10. DS Keith GA Nichols CM Gullion JB Brown DH Smith 2004 Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 659 663 15037495 10.1001/archinte.164.6.659 (Pubitemid 38392981)
11. T Inoue S Oshiro K Iseki M Tozawa T Touma Y Ikemiya, et al. 2001 High heart rate relates to clustering of cardiovascular risk factors in a screened cohort Jpn Circ J 65 969 973 11716249 10.1253/jcj.65.969 1:STN:280: DC%2BD3MnntVantg%3D%3D (Pubitemid 33035621)
12. K Iseki K Kohagura A Sakima C Iseki K Kinjo Y Ikemiya, et al. 2007 Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003) Hypertens Res 30 55 62 17460372 10.1291/hypres.30.55 1:CAS:528:DC%2BD2sXjvFWltbw%3D (Pubitemid 46259799)
13. AS Levey J Coresh T Greene LA Stevens YL Zhang S Hendriksen, et al. 2006 Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 247 254 16908915 1:CAS:528:DC%2BD28XpsFejtbo%3D
14. JD Kopple 2001 National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure Am J Kidney Dis 37 S66 S70 11158865 10.1053/ajkd.2001.20748 1:STN:280:DC%2BD3M3is1amtg%3D%3D
15. P Palatini S Julius 1997 Heart rate and the cardiovascular risk J Hypertens 15 3 17 9050965 10.1097/00004872-199715010-00001 1:STN:280: DyaK2s3gtlantQ%3D%3D (Pubitemid 27075981)
16. T Inoue K Iseki C Iseki Y Ohya K Kinjo S Takishita 2008 Association between heart rate and multiple risk factor syndrome Circ J 72 454 457 18296845 10.1253/circj.72.454 1:CAS:528:DC%2BD1cXktVSgtLo%3D (Pubitemid 351600642)
17. K Iseki Y Ikemiya C Iseki S Takishita 2003 Proteinuria and the risk of developing end-stage renal disease Kidney Int 63 1468 1474 12631363 10.1046/j.1523-1755.2003.00868.x (Pubitemid 36350012)
18. HA Koomans PJ Blankestijn JA Joles 2004 Sympathetic hyperactivity in chronic renal failure: a wake-up call J Am Soc Nephrol 15 524 537 14978154 10.1097/01.ASN.0000113320.57127.B9 (Pubitemid 38294782)
19. PA Sarafidis LM Ruilope 2006 Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications Am J Nephrol 26 232 244 16733348 10.1159/000093632 (Pubitemid 44114394)
20. S Klahr JJ Morrissey 2000 The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease Kidney Int Suppl 75 S7 S14 10828755 10.1046/j.1523-1755.2000.07509.x 1:CAS:528:DC%2BD3cXjtVOrsL8%3D
21. MJ Klag PK Whelton BL Randall JD Neaton FL Brancati CE Ford, et al. 1996 Blood pressure and end-stage renal disease in men N Engl J Med 334 13 18 7494564 10.1056/NEJM199601043340103 1:STN:280:DyaK287gsFakug%3D%3D (Pubitemid 26012498)
22. M Tozawa K Iseki C Iseki K Kinjo Y Ikemiya S Takishita 2003 Blood pressure predicts risk of developing end-stage renal disease in men and women Hypertension 41 1341 1345 12707291 10.1161/01.HYP.0000069699.92349.8C 1:CAS:528:DC%2BD3sXktVynu7c%3D (Pubitemid 36706087)
23. M Tozawa K Iseki C Iseki S Oshiro Y Ikemiya S Takishita 2002 Influence of smoking and obesity on the development of proteinuria Kidney Int 62 956 962 12164878 10.1046/j.1523-1755.2002.00506.x (Pubitemid 35316725)
24. J Chen P Muntner LL Hamm DW Jones V Batuman V Fonseca, et al. 2004 The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 167 174 14757614
25. F Locatelli P Pozzoni L Del Vecchio 2006 Renal manifestations in the metabolic syndrome J Am Soc Nephrol 17 S81 S85 16565254 10.1681/ASN.2005121332
26. JR Henegar SA Bigler LK Henegar SC Tyagi JE Hall 2001 Functional and structural changes in the kidney in the early stages of obesity J Am Soc Nephrol 12 1211 1217 11373344 1:STN:280:DC%2BD3Mzjt1OnsA%3D%3D
27. M Tozawa K Iseki C Iseki S Oshiro Y Ikemiya S Takishita 2002 Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria Kidney Int 62 1743 1749 12371975 10.1046/j.1523-1755.2002.00626.x 1:CAS:528:DC%2BD38Xos1ekt7o%3D (Pubitemid 35286282)
28. WF Keane MP O'Donnell BL Kasiske Y Kim 1993 Oxidative modification of low-density lipoproteins by mesangial cells J Am Soc Nephrol 4 187 194 8400082 1:CAS:528:DyaK2cXhtVCjsr8%3D
29. M Kurella JC Lo GM Chertow 2005 Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults J Am Soc Nephrol 16 2134 2140 15901764 10.1681/ASN.2005010106 (Pubitemid 41716445)
30. M Tozawa C Iseki K Tokashiki S Chinen K Kohagura K Kinjo, et al. 2007 Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults Hypertens Res 30 937 943 18049025 10.1291/hypres.30.937 1:CAS:528:DC%2BD1cXht12lsLw%3D (Pubitemid 350120971)
31. K Yamagata K Iseki K Nitta H Imai Y Iino S Matsuo, et al. 2008 Chronic kidney disease perspectives in Japan and the importance of urinalysis screening Clin Exp Nephrol 12 1 8 18175065 10.1007/s10157-007-0010-9
32. LE Boulware BG Jaar ME Tarver-Carr FL Brancati NR Powe 2003 Screening for proteinuria in US adults: a cost-effectiveness analysis JAMA 290 3101 3114 14679273 10.1001/jama.290.23.3101 1:CAS:528:DC%2BD3sXpvFKjtLw%3D (Pubitemid 37548116)
33. P Palatini E Casiglia P Pauletto J Staessen N Kaciroti S Julius 1997 Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations Hypertension 30 1267 1273 9369286 1:STN:280:DyaK1c%2FjsVaiuw%3D%3D
34. P Palatini 1999 Need for a revision of the normal limits of resting heart rate Hypertension 33 622 625 10024317 1:STN:280:DyaK1M7kvVWrug%3D%3D
35. T Inoue K Iseki C Iseki K Kinjo Y Ohya S Takishita 2007 Heart rate as a risk factor for development of chronic kidney disease-the longitudinal analysis of the screened cohort J Am Soc Nephrol 18 313A